Patent ductus arteriosus and pulmonary hypertension in related Pembroke Welsh corgis
Related Experiment Video
Updated: Aug 14, 2026

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
1Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins 80523.
Abstract:
Patent ductus arteriosus (PDA) and pulmonary hypertension were diagnosed in 5 related 12- to 24-week-old Pembroke Welsh Corgi dogs. A ductus diverticulum and small PDA were diagnosed in the pups' sire. Multiple factors likely contribute to the early development of pulmonary hypertension, including pulmonary hyperperfusion, genetic predisposition, and atmospheric pressure. The dogs of this report had a strong genetic predisposition to PDA, had large-diameter PDA associated with pulmonary hyperperfusion, and lived at altitudes of 5,000 to 7,000 feet above sea level. This combination of factors likely had an additive influence on the pulmonary vasculature, resulting in accelerated development of pulmonary hypertension in these dogs. Early recognition and treatment of PDA is critical in this setting before the development of severe pulmonary hypertension and uncorrectable disease.
More Related Videos
08:34Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
07:02A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep
Published on: July 15, 2021
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Cardiomyopathy II: Dilated Cardiomyopathy
Pulmonary Edema II: Pathophysiology